Advertisement
Study provides Class III evidence that assay distinguishes disease from normal controls
New tool for general neurologists aims to streamline differential diagnosis
Patient history plays a key role in identifying the condition
Chronic stress, asymptomatic disease affect different brains differently
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Researchers use patient data to strengthen clinical prediction models
Cleveland Clinic Cognitive Battery identifies at-risk patients during Medicare annual visits
Pairing machine learning with multi-omics revealed potential therapeutic targets
Awards fund research on oxidative targets, immunometabolism, spatial navigation testing and more
Recognizing this association aids risk assessment before starting novel immunotherapies
GFAP elevation may signal increased risk of progressive regional atrophy, cognitive decline
Advertisement
Advertisement